{
    "clinical_study": {
        "@rank": "26633", 
        "arm_group": {
            "arm_group_label": "Indigo Carmine", 
            "arm_group_type": "Experimental", 
            "description": "Intraoperative stereotactic injection of Indigo Carmine"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate whether stereotactic indigo carmine injection\n      can safely increase the extent of tumor resection."
        }, 
        "brief_title": "Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection", 
        "condition": "Brain Tumors With Ill-defined Margins", 
        "condition_browse": {
            "mesh_term": "Brain Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with gliomas or other tumors that may have ill defined margins during the\n             operative resection.\n\n        Exclusion Criteria:\n\n          -  Subjects with a contraindication for brain MRI scan.  Subjects who are pregnant,\n             younger than 18 years old or have a contraindication for indigo carmine are excluded\n             as well"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01767415", 
            "org_study_id": "1106011772"
        }, 
        "intervention": {
            "arm_group_label": "Indigo Carmine", 
            "intervention_name": "Indigo carmine", 
            "intervention_type": "Drug", 
            "other_name": "Indigotindisulfonate sodium"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 10, 2013", 
        "location": {
            "contact": {
                "email": "kom2001@med.cornell.edu", 
                "last_name": "Konstantinos Margetis, MD"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10065"
                }, 
                "name": "Weill Cornell Medical College Department of Neurological Surgery"
            }, 
            "investigator": [
                {
                    "last_name": "Theodore Schwartz, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Jeffrey Greenfield, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Konstantinos Margetis, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "kom2001@med.cornell.edu", 
            "last_name": "Konstantinos Margetis, MD", 
            "phone": "212-746-2363", 
            "phone_ext": "2"
        }, 
        "overall_contact_backup": {
            "email": "taw2015@med.cornell.edu", 
            "last_name": "Tamika Wong", 
            "phone": "212-746-1788"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Evaluation of the extent of resection of the tumor following the indigo carmine infusion to the tumor.", 
                "measure": "Extent of Resection", 
                "safety_issue": "No", 
                "time_frame": "48 hours"
            }, 
            {
                "measure": "Absence of complications after injection", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01767415"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Weill Medical College of Cornell University", 
            "investigator_full_name": "Theodore H. Schwartz", 
            "investigator_title": "Professor of Neurological Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Weill Medical College of Cornell University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Weill Medical College of Cornell University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}